Evidence map›Paper›PMID 29155097›Full record

ArticleThe Journal of allergy and clinical immunology2018

14-3-3z sequesters cytosolic T-bet, upregulating IL-13 levels in T

Sandra Cascio, Thomas A Medsger, William F Hawse, Simon C Watkins, Christine Milcarek, Larry W Moreland, Robert A Lafyatis, Patrizia Fuschiotti

Abstract read
In one paragraph

Article in The Journal of allergy and clinical immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Treatable Traits in Systemic Sclerosis.Clinical reviews in allergy & immunology · 2023
    Review
  3. Article
  4. Review
  5. Article
  6. CD8International journal of molecular sciences · 2022
    Review
  7. Article
  8. Review
  9. Paraclinical Aspects in Systemic Sclerosis.International journal of general medicine · 2022
    Review
  10. Review
  11. Article
  12. Serum 14-3-3β protein: a new biomarker in asthmatic patients with acute exacerbation in an observational study.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2021
    Article
  13. Review
  14. Article
  15. 14-3-3ζ-TRAF5 axis governs interleukin-17A signaling.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 2 countries.

Sandra CascioDepartment of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, Pa; RiMED Foundation, Palermo, Italy.
Thomas A MedsgerDepartment of Medicine, Division of Rheumatology and Clinical Immunology, University of Pittsburgh School of Medicine, Pittsburgh, Pa.
William F HawseDepartment of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, Pa.
Simon C WatkinsDepartment of Cell Biology, University of Pittsburgh School of Medicine, Pittsburgh, Pa.
Christine MilcarekDepartment of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, Pa.
Larry W MorelandDepartment of Medicine, Division of Rheumatology and Clinical Immunology, University of Pittsburgh School of Medicine, Pittsburgh, Pa.
Robert A LafyatisDepartment of Medicine, Division of Rheumatology and Clinical Immunology, University of Pittsburgh School of Medicine, Pittsburgh, Pa.
Patrizia FuschiottiDepartment of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, Pa; Department of Medicine, Division of Rheumatology and Clinical Immunology, University of Pittsburgh School of Medicine, Pittsburgh, Pa. Electronic address: paf23@pitt.edu.
University of Pittsburgh · US

Funding

Transcription elongation in B cell differentiationR21AI124241 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI MILCAREK, CHRISTINE ANN · 2016 to 2017
$425k
Pathogenesis of systemic sclerosis: role of the skin-resident CD8+ T cellsR03AR065755 · NIAMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI FUSCHIOTTI, PATRIZIA · 2014 to 2016
$231k
NIAID NIH HHS R21 AI124241NIAMS NIH HHS R03 AR065755
6 · The paper itself

Abstract

backgroundIL-13-producing CD8

objectiveWe sought to establish the molecular basis of IL-13 overproduction by CD8

methodsBiochemical and biophysical methods were used to determine the expression and association of T-bet, GATA-3, and regulatory factors in CD8

resultsInteraction of T-bet with the adaptor protein 14-3-3z in the cytosol of CD8

conclusionsWe identified a novel molecular mechanism underlying type 2 cytokine production by CD8

Indexed as

14-3-3 ProteinsAdultAgedCD8-Positive T-LymphocytesCytokinesCytosolFemaleFibrosisGATA3 Transcription FactorGene Expression RegulationHumansInterleukin-13MaleMiddle AgedScleroderma, SystemicT-bet Transcription Factor14-3-3 ProteinsCytokinesGATA3 Transcription FactorIL13 protein, humanInterleukin-13T-bet Transcription FactorT-Box Domain ProteinsYWHAZ protein, human14-3-3IL-13systemic sclerosisT-betT(C)2

Identifiers

PMID29155097
PMCPMC5953767
OpenAlexW2768686928

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.